Management of cutaneous lupus erythematosus with Janus kinase inhibitor therapy: An evidence-based review

J Am Acad Dermatol. 2023 Jul;89(1):130-131. doi: 10.1016/j.jaad.2022.12.037. Epub 2023 Mar 18.
No abstract available

Keywords: JAK inhibitor; TYK2; cutaneous lupus erythematosus; evidence-based; systematic review; therapeutics; treatment.

Publication types

  • Review

MeSH terms

  • Humans
  • Janus Kinase Inhibitors* / therapeutic use
  • Janus Kinases
  • Lupus Erythematosus, Cutaneous* / drug therapy
  • Lupus Erythematosus, Systemic* / drug therapy
  • Molecular Targeted Therapy

Substances

  • Janus Kinase Inhibitors
  • Janus Kinases